본문 바로가기
KERD
논문KCI 등재

섬유근통증후군

Fibromyalgia Syndrome

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류신경과학

초록

Fibromyalgia is a chronic pain syndrome of unknown etiology that is characterized by diffuse musculoskeletal pain,fatigue, sleep disturbance, memory disturbance, and exaggerated tenderness over particular paired locations. Fibromyalgia is found in 2% to 4% of the general population and more common in women, with symptoms usually appearing between 20 and 55 years of age. The diagnostic criteria for fibromyalgia syndrome established in 1990 by the American College of Rheumatology (ACR), includes widespread pain for at least 3 months and point tenderness upon the application of a 4 kg weight at 11 or more of the 18 characteristic tender points. The 2010 ACR preliminary diagnostic criteria have been developed, which are strongly correlated with the 1990 ACR criteria and provide an alternative approach to diagnosis. Patients with fibromyalgia syndrome have lower pain thresholds and experience an altered temporal summation to pain stimuli. The sensitization of pain perception occurs in the dorsal horn of patients with fibromyalgia. However, it is unknown whether sensitization is due to increased pain fiber facilitation, or decreased inhibition. Pregabalin is approved by the United States Food and Drug Administration for the management of fibromyalgia patients. Tricyclic antidepressants, cardiovascular exercise, cognitive behavioral therapy and patient education are also effective in reducing the pain experienced by fibromyalgia patients. This article provides an overview of fibromyalgia syndrome, which is currently thought to be partly responsible for chronic diffuse pain.

Abstract

Fibromyalgia is a chronic pain syndrome of unknown etiology that is characterized by diffuse musculoskeletal pain,fatigue, sleep disturbance, memory disturbance, and exaggerated tenderness over particular paired locations. Fibromyalgia is found in 2% to 4% of the general population and more common in women, with symptoms usually appearing between 20 and 55 years of age. The diagnostic criteria for fibromyalgia syndrome established in 1990 by the American College of Rheumatology (ACR), includes widespread pain for at least 3 months and point tenderness upon the application of a 4 kg weight at 11 or more of the 18 characteristic tender points. The 2010 ACR preliminary diagnostic criteria have been developed, which are strongly correlated with the 1990 ACR criteria and provide an alternative approach to diagnosis. Patients with fibromyalgia syndrome have lower pain thresholds and experience an altered temporal summation to pain stimuli. The sensitization of pain perception occurs in the dorsal horn of patients with fibromyalgia. However, it is unknown whether sensitization is due to increased pain fiber facilitation, or decreased inhibition. Pregabalin is approved by the United States Food and Drug Administration for the management of fibromyalgia patients. Tricyclic antidepressants, cardiovascular exercise, cognitive behavioral therapy and patient education are also effective in reducing the pain experienced by fibromyalgia patients. This article provides an overview of fibromyalgia syndrome, which is currently thought to be partly responsible for chronic diffuse pain.

참고문헌 (49)

  1. Goldenberg DL, "Fibromyalgia syndrome. An emerging but controversial condition", JAMA, 257, pp.2782~2787 (1987)
  2. Goldenberg DL, "Fibromyalgia syndrome a decade later : what have we learned?", Arch Intern Med, 159, pp.777~785 (1999)
  3. Weir PT, "The incidence of fibromyalgia and its associated comorbidities : a population- based retrospective cohort study based on International Classification of Diseases, 9th Revision codes", J Clin Rheumatol, 12, pp.124~128 (2006)
  4. Bannwarth B, "Fibromyalgia syndrome in the general population of France : a prevalence study", Joint Bone Spine, 76, pp.184~187 (2009)
  5. Glass JM, "Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome : new trends and future directions", Curr Rheumatol Rep, 8, pp.425~429 (2006)
  6. Marcus DA, "Fibromyalgia and headache : an epidemiological study supporting migraine as part of the fibromyalgia syndrome", Clin Rheumatol, 24, pp.595~601 (2005)
  7. Wolfe F, "The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee", Arthritis Rheum, 33, pp.160~172 (1990)
  8. Wolfe F, "The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity", Arthritis Care Res, 62, pp.600~610 (2010)
  9. Goldenberg DL, "Management of fibromyalgia syndrome", JAMA, 292, pp.2388~2395 (2004)
  10. Katz RS, "Fibromyalgia diagnosis : a comparison of clinical, survey, and American College of Rheumatology criteria", Arthritis Rheum, 54, pp.169~176 (2006)
  11. Shleyfer E, "Accuracy of the diagnosis of fibromyalgia by family physicians : is the pendulum shifting?", J Rheumatol, 36, pp.170~173 (2009)
  12. Croft P, "The prevalence of chronic widespread pain in the general population", J Rheumatol, 20, pp.710~713 (1993)
  13. Croft P, "Population study of tender point counts and pain as evidence of fibromyalgia", BMJ, 309, pp.696~699 (1994)
  14. Brodal A., "Neurological anatomy in relation to clinical medicine. 3rd ed" (1981), Oxford University Press
  15. Young PA, "The anatomy of the spinal cord pain paths : A review", J Am Paraplegia Soc, 9, pp.28~38 (1986)
  16. Basbaum AI, "Conduction of the effects of noxious stimulation by short fiber multisynaptic systems of the spinal cord in rat", Exp Neurol, 40, pp.699~716 (1973)
  17. Bennett GJ, "The morphology of dorsal column post-synaptic spinomedullary neurons in the cat", J Comp Neurol, 224, pp.568~574 (1984)
  18. Basbaum AI., "Anatomical substrates of pain and pain modulation and their relationship to analgesic drugs, In Analgesics : Neurochemical, behavioral and clinical perspective" (1984), Raven Press
  19. Ralston HR, "Synaptic organization of the spinothalamic tract projection to the thalamus with special reference to pain, In Advances in pain Research and Therapy. Vol. 6" (1984), Raven Press
  20. Melzack R, "Pain mechanisms : A new theory", Science, 150, pp.971~979 (1965)
  21. Krout KE, "Periaqueductal gray matter projection to the parabrachial nuelcus in the rat", J Comp Neurol, 401, pp.437~454 (1998)
  22. Basbaum AI, "Opiate and stimulus-produced analgesia : Functional anatomy of a medullospinal pathway", Proc Natl Acad Sci U S A, 73, pp.4685~4688 (1976)
  23. Fields HL, "Anatomy and physiology of a nociceptive modulatory system", Philos Trans R Soc Lond B Biol Sci, 308, pp.361~374 (1985)
  24. Fields HL, "Central nervous system mechanism of pain modulation, In Wall and Melzak’s textbook of pain. 5th ed", pp.125~142 (2006), Elsevier Churchill Livingstone
  25. Cook DB, "Functional imaging of pain in patients with primary fibromyalgia", J Rheumatol, 31, pp.364~378 (2004)
  26. Staud R, "Abnormal sensitization and temporal summation of second pain(wind-up)in patients with fibromyalgia syndrome", Pain, 91, pp.165~175 (2001)
  27. Staud R, "Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome", Pain, 102, pp.87~95 (2003)
  28. Kosek E, "Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation(HNCS)in fibromyalgia patients and healthy subjects", Pain, 70, pp.41~51 (1997)
  29. Gebhart GF, "Descending modulation of pain", Neurosci Biobehav Rev, 27, pp.729~737 (2004)
  30. Watkins LR, "Evidence for the involvement of spinal cord glial in subcutaneous formalin induced hyperalgesia in the rat", Pain, 71, pp.225~235 (1997)
  31. Raghavendra V, "Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy", J Pharmacol Exp Ther, 306, pp.624~630 (2003)
  32. Coury F, "Rheumatoid arthritis and fibromyalgia : a frequent unrelated association complicating disease management", J Rheumatol, 36, pp.58~62 (2009)
  33. Kato K, "Chronic widespread pain and its comorbidities : a population-based study", Arch Intern Med, 166, pp.1649~1654 (2006)
  34. Cole JA, "Migraine, fibromyalgia and depression among people with IBS : a prevalence study", BMC Gastroenterol, 6, pp.26~ (2006)
  35. Tunks E, "Regional soft tissue pains : alias myofascial pain?", Baillieres Best Pract Res Clin Rheumatol, 13, pp.345~369 (1999)
  36. Carette S, "Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study", Arthritis Rheum, 29, pp.655~659 (1986)
  37. Goldenberg DL, "Randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia", Arthritis Rheum, 29, pp.1371~1377 (1986)
  38. Carette S, "Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia : A randomized, double-blind clinical trial", Arthritis Rheum, 37, pp.32~40 (1994)
  39. Tofferi JK, "Treatment of fibromyalgia with cyclobenzaprine : a meta-analysis", Arthritis Rheum, 51, pp.9~13 (2004)
  40. Crofford LJ, "Pregabalin for the treatment of fibromyalgia syndrome : results of a randomized, double-blind, placebo-controlled trial", Arthritis Rheum, 52, pp.1264~1273 (2005)
  41. Hauser W, "Treatment of fibromyalgia syndrome with gabapentin and pregabalin : a meta-analysis of randomized controlled trials", Pain, 145, pp.69~81 (2009)
  42. Russell IJ, "Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder : results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial", Pain, 136, pp.432~444 (2008)
  43. Branco JC, "A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia", J Rheumatol, 37, pp.851~859 (2010)
  44. Bennett RM, "Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain : a double-blind, randomized, placebo-controlled study", Am J Med, 114, pp.537~545 (2003)
  45. Busch AJ, "Exercise for fibromyalgia : a systemic review", J Rheuamtol, 35, pp.1130~1144 (2008)
  46. Bircan C, "Effects of muscle strengthening versus aerobic exercise program in fibromyalgia", Rheumatol Int, 28, pp.527~532 (2008)
  47. Gusi N, "Cost-utility of an 8-month aquatic training for women with fibromyalgia : a randomized controlled trial", Arthritis Res Ther, 10, pp.24~ (2008)
  48. White KP, "Cognitive behavioral treatment of fibromyalgia syndrome : a followup assessment", J Rheumatol, 22, pp.717~721 (1995)
  49. Rooks DS, "Group exercise, education, and combination self-management in women with fibromyalgia : a randomized trial", Arch Intern Med, 167, pp.2192~2200 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (23건)